Drug Database
Back to search

France· FR:62722988

AZILECT 1 mg, comprimé

A rasagiline product containing mésilate de rasagiline, registered in France by TEVA (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 19 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N04BD02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedAZILECT 1 mg, compriméATCN04BD02REGISTER NO.FR:62722988PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mésilate de rasagilineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Rasagiline is registered in 19 of 19 countries.

Countries holding a registration under ATC N04BD02 (rasagiline), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 11 of them publish a price we can compare per daily dose
Search rasagiline products by name

Rasagiline · ATC N04BD02

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rasagiline costs, country by country.

Normalised to the WHO defined daily dose (1 mg), the median price runs from $1.28 in France to $3.47 in Spain — a ×2.7 gap.

  • France: $1.28 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Rasagiline · price per daily dose (1 mg)

USD · FX 28 Sept 2026

  • ES Spain$3.47
  • CH Switzerland$3.02
  • IT Italy$2.36
  • FR France$1.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MÉSILATE DE RASAGILINE
Manufacturer
TEVA (PAYS-BAS)
Country
France (FR)
ATC code
N04BD02
ATC class
Rasagiline
Defined daily dose
1 mg, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400936578357
    plaquette(s) thermoformée(s) aluminium de 30 comprimé(s)
    EUR 33.8
  • cip13
    3400949500505
    plaquette(s) thermoformée(s) aluminium de 30 comprimé(s) (distributeur parallèle : BB FARMA s.r.l)
    EUR 33.8

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

200 interactions on record for rasagiline.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check rasagiline against other medicinesHow interaction checks work

Rasagiline · interactions on record

200 records

  • 28 severe
  • 157 moderate

Most severe, free to view

  • FenfluramineA08AA02severe
  • DexfenfluramineA08AA04severe
  • SibutramineA08AA10severe
  • TiclopidineB01AC05severe

15 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rasagiline in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rasagiline products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Rasagilin +pharma, Rasagilin 1a Pharma
  • Belgium · Rasagiline Eg, Rasagiline Krka
  • Bulgaria · Ралаго, Сагилия
  • Cyprus · Azipron, Rasagiline Krka
  • Czechia · Detreman, Ralago
  • Germany · Rasagea, Rasagilin 1 A Pharma
  • Denmark · Rasagilin Accord, Rasagilin Glenmark
  • Estonia · Ralago, Sagilia
  • Spain · Altina, Neuromiol
  • Finland · Rasabon, Rasagilin
  • United Kingdom (Northern Ireland) · Azilect, Rasagiline
  • Greece · Asarkin, Ractilen
  • Croatia · Azipron, Ralago
  • Hungary · Ralago, Rasagiline Stada
  • Ireland · Rasagiline Accord, Rasagiline Clonmel
  • Iceland · Azilect, Rasagilin Krka
  • Italy · Aidex, Nalisar
  • Liechtenstein · Azilect, Rasagiline Ratiopharm
  • Lithuania · Ralago, Rasagiline Sandoz
  • Luxembourg · Rasagilin Micro Labs, Rasagiline Eg
  • Latvia · Ralago
  • Malta · Rasagiline Ascend, Sagilia
  • Netherlands · Rasagiline Aurobindo, Rasagiline Bioorganics
  • Norway · Azilect, Rasagilin Accord
  • Poland · Asanix, Detreman
  • Portugal · Detreman, Rasagilina Alras Alter
  • Romania · Hiperavia, Sagilia
  • Sweden · Rasagilin Glenmark, Rasagilin Krka
  • Slovenia · Ralago, Razagilin Krka
  • Slovakia · Ralago, Rasagiline Egis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dea9242b-2b81-40ba-90f3-9788e6a542ba
GET /v1/drugs/dea9242b-2b81-40ba-90f3-9788e6a542ba?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62722988",
  "date_amm": "2005-02-21",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/04/304",
  "substance": "MÉSILATE DE RASAGILINE",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}
API referenceMCP serverPlans

See everything about rasagiline.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console